CLINICAL_TRIALS
trial_result
· 2021-12-29
Clinical Trial Update: Intravitreal Brolucizumab in Neovascular Age-related Macular Degeneration With Limited Response to Aflibercept [Phase 4]
Summary
Clinical trial update for intravitreal brolucizumab in neovascular age-related macular degeneration with limited response to aflibercept; study terminated in Ph…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vista Klinik | Conditions: Neovascular Age-related Macular Degeneration | Phase 4 | Status: TERMINATED